37 CFR § 1.824 — Form and format for a nucleotide and/or amino (MPEP Coverage Index) – BlueIron IP

37 CFR § 1.824 Form and format for a nucleotide and/or amino

Source: Patent Rule (37 CFR)BlueIron Update:

This page consolidates MPEP guidance interpreting 37 CFR § 1.824, including 70 rules from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.

Summary

37 CFR 1.824 establishes precise technical requirements for documenting and electronically submitting genetic sequence information in patent applications.

What this section covers

  • Outline specific requirements for documenting nucleotide and amino acid sequences in patent applications.
  • Define technical specifications for sequence listing submissions in patent documentation.

Key obligations

  • Require a separate computer-readable form (CRF) of the Sequence Listing for patent applications.
  • Include a specific statement in the specification that incorporates the Sequence Listing by reference.

Practice notes

  • Ensure precise formatting of sequence data to meet USPTO computational requirements.
  • Verify that sequence listings comply with specific technical standards for electronic submission.

Related Provisions

Based on MPEP Last Modified: 10/30/2024 08:50:22